These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10419506)

  • 1. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation.
    Haardt M; Benharouga M; Lechardeur D; Kartner N; Lukacs GL
    J Biol Chem; 1999 Jul; 274(31):21873-7. PubMed ID: 10419506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.
    Benharouga M; Haardt M; Kartner N; Lukacs GL
    J Cell Biol; 2001 May; 153(5):957-70. PubMed ID: 11381082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.
    Seibert FS; Linsdell P; Loo TW; Hanrahan JW; Clarke DM; Riordan JR
    J Biol Chem; 1996 Jun; 271(25):15139-45. PubMed ID: 8662892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator.
    Schwiebert EM; Morales MM; Devidas S; Egan ME; Guggino WB
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2674-9. PubMed ID: 9482946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia.
    Benharouga M; Sharma M; So J; Haardt M; Drzymala L; Popov M; Schwapach B; Grinstein S; Du K; Lukacs GL
    J Biol Chem; 2003 Jun; 278(24):22079-89. PubMed ID: 12651858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.
    Seibert FS; Linsdell P; Loo TW; Hanrahan JW; Riordan JR; Clarke DM
    J Biol Chem; 1996 Nov; 271(44):27493-9. PubMed ID: 8910333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved region of the R domain of cystic fibrosis transmembrane conductance regulator is important in processing and function.
    Pasyk EA; Morin XK; Zeman P; Garami E; Galley K; Huan LJ; Wang Y; Bear CE
    J Biol Chem; 1998 Nov; 273(48):31759-64. PubMed ID: 9822639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes.
    Xie J; Drumm ML; Zhao J; Ma J; Davis PB
    Biophys J; 1996 Dec; 71(6):3148-56. PubMed ID: 8968585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
    Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
    J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
    Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
    J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of cystic fibrosis transmembrane conductance regulator.
    Pranke IM; Sermet-Gaudelus I
    Int J Biochem Cell Biol; 2014 Jul; 52():26-38. PubMed ID: 24685677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis mutations lead to carboxyl-terminal fragments that highlight an early biogenesis step of the cystic fibrosis transmembrane conductance regulator.
    Van Oene M; Lukacs GL; Rommens JM
    J Biol Chem; 2000 Jun; 275(26):19577-84. PubMed ID: 10764788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of DeltaF508 CFTR in an epithelial monolayer.
    Bebök Z; Venglarik CJ; Pánczél Z; Jilling T; Kirk KL; Sorscher EJ
    Am J Physiol; 1998 Aug; 275(2):C599-607. PubMed ID: 9688615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved maturation of CFTR by an ER export signal.
    Wendeler MW; Nufer O; Hauri HP
    FASEB J; 2007 Aug; 21(10):2352-8. PubMed ID: 17392477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and intracellular processing of chimeric and mutant CFTR molecules.
    Pollet JF; Van Geffel J; Van Stevens E; Van Geffel R; Beauwens R; Bollen A; Jacobs P
    Biochim Biophys Acta; 2000 Jan; 1500(1):59-69. PubMed ID: 10564718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
    Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
    Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.